The overexpression of PD-L1 in many cancers causes functionally exhausted and unresponsive T cells, promoting immune evasion and tumor progression (7, 11–13) and abrogating PD-L1 expression on tumor cells can enhance sensitivity to T cell killing (40, 41). The gene discussed is CD274; the disease is neoplasm.